Connection

Samar Hammad to Sphingolipids

Back to Details
This is a "connection" page, showing publications Samar Hammad has written about Sphingolipids.
Samar Hammad
Connection Strength
4.774
Sphingolipids
  1. Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. J Clin Lipidol. 2022 Mar-Apr; 16(2):173-183.
    View in: PubMed
    Score: 0.617
  2. Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value. Front Immunol. 2021; 12:694318.
    View in: PubMed
    Score: 0.598
  3. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus. Front Immunol. 2020; 11:586737.
    View in: PubMed
    Score: 0.565
  4. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins. Genes (Basel). 2020 02 07; 11(2).
    View in: PubMed
    Score: 0.540
  5. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity. PLoS One. 2019; 14(11):e0224496.
    View in: PubMed
    Score: 0.532
  6. Sphingolipids as Biomarkers of Disease. Adv Exp Med Biol. 2019; 1159:109-138.
    View in: PubMed
    Score: 0.501
  7. Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupus. Cell Immunol. 2012 Mar-Apr; 276(1-2):42-51.
    View in: PubMed
    Score: 0.314
  8. Blood sphingolipids in homeostasis and pathobiology. Adv Exp Med Biol. 2011; 721:57-66.
    View in: PubMed
    Score: 0.288
  9. Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J Lipid Res. 2010 Oct; 51(10):3074-87.
    View in: PubMed
    Score: 0.279
  10. Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes. J Clin Lipidol. 2019 May - Jun; 13(3):481-491.e1.
    View in: PubMed
    Score: 0.127
  11. Sphingolipids and Lipoproteins in Health and Metabolic Disorders. Trends Endocrinol Metab. 2017 07; 28(7):506-518.
    View in: PubMed
    Score: 0.111
  12. Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study. Neuromolecular Med. 2017 Mar; 19(1):46-56.
    View in: PubMed
    Score: 0.105
  13. Accelerated vascular disease in systemic lupus erythematosus: role of macrophage. Clin Immunol. 2015 Apr; 157(2):133-44.
    View in: PubMed
    Score: 0.095
  14. 3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish. Sci Rep. 2019 02 04; 9(1):1138.
    View in: PubMed
    Score: 0.031
  15. ATP binding cassette family A protein 1 determines hexosylceramide and sphingomyelin levels in human and mouse plasma. J Lipid Res. 2018 11; 59(11):2084-2097.
    View in: PubMed
    Score: 0.031
  16. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes. Metabolism. 2014 Oct; 63(10):1287-95.
    View in: PubMed
    Score: 0.023
  17. HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res. 2010 Sep; 51(9):2619-28.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.